- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Rare Neoplastic Syndrome in United States
Total 68378 results
-
Opsona Therapeutics Ltd.M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaboratorsCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
Rush University Medical CenterH. Lundbeck A/STerminatedMyelodysplastic SyndromeUnited States
-
Arno TherapeuticsUnknown
-
Northwestern UniversityRobert H. Lurie Cancer CenterTerminatedMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.Completed
-
M.D. Anderson Cancer CenterCompletedMyelodysplastic SyndromeUnited States
-
Veeda OncologyCephalonTerminatedMyelodysplastic SyndromeUnited States
-
National Institutes of Health Clinical Center (CC)CompletedMyelodysplastic Syndromes | Hematologic DiseasesUnited States
-
University of Wisconsin, MadisonTerminatedCompartment Syndrome of LegUnited States
-
University of NebraskaEli Lilly and CompanyTerminatedShort Bowel SyndromeUnited States
-
ShireTakeda Development Center Americas, Inc.Active, not recruiting
-
Mayo ClinicCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Washington University School of MedicineSunesis PharmaceuticalsCompletedMyelodysplastic SyndromesUnited States
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
Tarix PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)United States
-
Thomas Jefferson UniversityWithdrawnMyelodysplastic SyndromesUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Alliance for Cancer Gene TherapyTerminatedMyelodysplastic SyndromesUnited States
-
CelgeneCompletedMyelodysplastic SyndromeUnited States
-
University of FloridaGateway for Cancer Research; Cellworks Group Inc.WithdrawniCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesUnited States
-
Lixte Biotechnology Holdings, Inc.UnknownMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Neal Young, M.D.CompletedMyelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompletedMyelodysplastic SyndromesUnited States
-
Dartmouth-Hitchcock Medical CenterDartmouth CollegeRecruitingCompartment Syndromes | Compartment Syndrome of Forearm | Compartment Syndrome of Lower LegUnited States
-
UNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina, Chapel Hill; National Center for Advancing Translational... and other collaboratorsRecruitingLynch SyndromeUnited States
-
Cyclacel Pharmaceuticals, Inc.SuspendedLeukemia | Myelodysplastic Syndrome(MDS)United States
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Stanford UniversityNational Institutes of Health (NIH)CompletedMyelodysplastic Syndromes | Myeloproliferative Disorders | Myelodysplastic Syndromes (MDS) | Blood and Marrow Transplant (BMT) | Myeloproliferative Disorders (MPD)United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingColorectal Cancer | Lynch Syndrome | T CellsUnited States
-
Kaiser PermanenteM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Vanderbilt University and other collaboratorsCompletedLynch Syndrome | Colon CancerUnited States
-
Ricardo MaselliCatalyst Pharmaceuticals, Inc.No longer availableCongenital Myasthenic SyndromeUnited States
-
Montefiore Medical CenterAlbert Einstein College of MedicineWithdrawnMyelodysplastic SyndromesUnited States
-
PersImmune, IncUniversity of California, San DiegoUnknownMyelodysplastic SyndromesUnited States
-
Roswell Park Cancer InstituteGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromeUnited States
-
University of RochesterCompletedMyelodysplastic SyndromesUnited States
-
Duke UniversityEisai Inc.; CephalonCompletedMyelodysplastic SyndromeUnited States
-
Lindsey Russell, MDNapo Pharmaceuticals, Inc.Not yet recruitingShort Bowel SyndromeUnited States
-
Boston Children's HospitalEntrinsic Bioscience Inc.TerminatedShort Bowel SyndromeUnited States
-
Le Bonheur Children's HospitalUniversity of Tennessee Health Science CenterUnknown
-
University of Colorado, DenverNo longer available
-
Children's Hospital Medical Center, CincinnatiApproved for marketingDravet SyndromeUnited States
-
J&M ShulerNonin Medical, IncCompletedAcute Compartment SyndromeUnited States
-
Alison WalkerSeagen Inc.TerminatedMyelodysplastic Syndromes | LeukemiaUnited States